Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
4 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Tandem Diabetes Care (NASDAQ: TNDM ) released second-quarter financial results and hosted an earnings call on Thursday. Read the complete transcript below. This transcript is brought to you APIs. For real-time access to our entire catalog, please visit for a consultation. Access the full call at Summary Tandem Diabetes
Lexicon Pharmaceuticals (NASDAQ: LXRX ) held its second-quarter earnings conference call on Thursday. Below is the complete transcript from the call. This transcript is brought to you APIs. For real-time access to our entire catalog, please visit for a consultation. The full earnings call is available at Summary Lexico
The European Commission has granted marketing authorization for Menarini Group and NewAmsterdam Pharma's Ubeslo® (obicetrapib 10 mg monotherapy) and Evlarco® (10 mg obicetrapib plus 10 mg ezetimibe fixed-dose combination) for patients with primary hypercholesterolaemia. This marks the first regulatory approval of obice
Tandem Diabetes Care files S-8 registration statement with SEC. The filing is related to the company's employee benefit plans.